Deadline Approaching: MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith

Group 1 - The article highlights the upcoming deadline of December 15, 2025, for investors to file a lead plaintiff motion in a case related to MoonLake Immunotherapeutics (NASDAQ: MLTX) [1] - The class period for the case is defined as between March 10, 2024, and September 29, 2025, during which investors purchased common stock of MoonLake [1] - Investors who suffered losses in MoonLake Immunotherapeutics are encouraged to contact the Law Offices of Howard G. Smith for assistance [1]